Submit Deal

Real Chemistry

Summary

Edit Data

Real Chemistry is a global health innovation company.

Market Context

Deals Overview

Edit Data

Total Deals6

Valued Deals5

Total Value£ 7.25 B

Avg. Deal Size£ 1.45 B

23 Feb 2023|United States|Biotechnology

Target: MEI PHARMA

Bidder: INFINITY PHARMACEUTICALS

8 Service Providers

4 Target | 4 Bidder

12 Dealmakers

10 Target | 2 Bidder

n/a

Value

29 Nov 2022|Netherlands|Biotechnology

Target: NEOGENE THERAPEUTICS

Bidder: ASTRAZENECA PLC

7 Service Providers

3 Target | 2 Bidder | 2 Vendor

60 Dealmakers

29 Target | 24 Bidder | 7 Vendor

£ 264 M

Value

21 Sep 2022|United States|Pharmaceuticals

Target: CARISMA THERAPEUTICS INC

Bidder: SESEN BIO

11 Service Providers

7 Target | 4 Bidder

15 Dealmakers

3 Target | 12 Bidder

£ 380 M

Value

02 Jul 2021|United States|Biotechnology

Target: PAREXEL

Bidder: GOLDMAN SACHS ASSET MANAGEMENT

14 Service Providers

4 Target | 8 Bidder | 2 Vendor

57 Dealmakers

6 Target | 49 Bidder | 2 Vendor

£ 6.17 B

Value

06 May 2021|United States|Biotechnology

Target: JASPER THERAPEUTICS INC

Bidder: AMPLITUDE HEALTHCARE ACQUISITION CORPORATION

12 Service Providers

7 Target | 5 Bidder

32 Dealmakers

29 Target | 3 Bidder

£ 350 M

Value

31 Mar 2021|United States|Biotechnology

Target: ENTRADA THERAPEUTICS INC

Bidder: WELLINGTON MANAGEMENT

16 Service Providers

2 Target | 14 Bidder

29 Dealmakers

5 Target | 25 Bidder

£ 84 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy